Page last updated: 2024-08-24

colestipol and Apolipoprotein B-100, Familial Defective

colestipol has been researched along with Apolipoprotein B-100, Familial Defective in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	53 (69.74)	18.7374
1990's	19 (25.00)	18.2507
2000's	4 (5.26)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asami, T; Uchiyama, M	1
Angelin, B; Berglund, L; Borgström, B; Eggertsen, G; Ericsson, S; Eriksson, M; Lind, S; Olivecrona, H; Rudling, M	1
Bilheimer, DW; Brown, MS; Goldstein, JL; Grundy, SM	3
Connor, WE; Illingworth, DR; Phillipson, BE; Rapp, JH	1
Chernoff, SB; Decoursey, S; Dujovne, CA; Garty, M; Jackson, B; Krehbiel, P; Pitterman, A	1
Myant, NB	1
Ambagtsheer, JJ; Dijkhuis-Stoffelsma, R; Fernandes, J; Groot, PH; Grose, WF	1
Illingworth, DR	1
Illingworth, DR; Sundberg, EE	1
Glueck, CJ	2
Farinaro, E; Mancini, M; Montefusco, S; Postiglione, A	1
Kuo, PT	1
Briones, ER; Kottke, BA; Palumbo, PJ; Steiger, D	1
Bayliss, CE; Carroll, GJ	1
Freedman, DD; Havel, RJ; Kane, JP; Malloy, MJ; Phillips, NR; Rowe, JS; Tun, P; Williams, ML	1
Kane, JP; Malloy, MJ	1
Havel, RJ; Kane, JP	2
Heilman, J; Linden, CV; O'Connell, MJ; Vecchio, TJ	1
Heuck, CC; Middelhoff, G; Mrozik, K; Oster, P; Riesen, W; Schellenberg, B; Schlierf, G	1
Kostis, JB; Kuo, PT; Moreyra, AE	1
Crow, LO; Hunninghake, DB; Isaacson, SO; Probstfield, JL	1
Bell, C; Hunninghake, DB; Olson, L	1
Boŝković, B; Gavrilović, M; Kuŝić, M; Mihajloviĉ, M	1
Haba, T; Kametani, T; Koizumi, J; Mabuchi, H; Miyamoto, S; Ohka, T; Ohta, M; Ono, S; Sakai, T; Sakai, Y; Takeda, R; Takegoshi, T; Takeshita, H; Tatami, R; Ueda, K; Ueda, R; Wakasugi, T; Watanabe, A; Yoshimura, A	1
Goldstein, PD; Schonfeld, G; Schwarz, KB; Witztum, JL	1
Debry, G; Demange, J; Drouin, P; Lambert, L; Sauvanet, JP	1
Crouse, JR; Grundy, SM	1
Hayes, JA; Kostis, JB; Kuo, PT; Moreyra, AE	1
Olbricht, CJ	1
Davies, G; Kitano, Y; Maher, VM; Matthews, S; Mir, A; Neuwirth, C; Prescott, RJ; Rees, A; Shortt, MB; Thompson, GR	1
Bacon, S; Illingworth, DR; Mahley, RW; Schmidt, EB; Weisgraber, KH	1
Aksnes, L; Ose, L; Sivertsen, M; Tonstad, S	1
Ose, L; Tonstad, S	1
Farmer, JA; Gotto, AM	1
Avery, BR	1
Knight, BL; Patel, DD; Soutar, AK; Sun, XM	1
Kitano, Y; Thompson, GR	1
Bourbon, M; Knight, BL; Naoumova, RP; Neuwirth, CK; O'Neill, FH; Patel, DD; Soutar, AK; Taylor, GW; Thompson, GR	1
Jacobs, LS; Schonfeld, G; Witztum, JL	1
Hansen, D; Michaelsen, KF; Skovby, F	1
Ceska, R; Sobra, J; Toschnerová, H; Traurig, J	2
Desager, JP; Harvengt, C; Horsmans, Y	1
Grafnetter, D; Jirkovská, A; Válek, J	1
Ast, M; Frishman, WH	1
Diehl, JC; Havel, RJ; Kane, JP; Malloy, MJ; Phillips, NR; Ports, TA	1
Demacker, PN; Mol, MJ; Stalenhoef, AF; Stuyt, PM	1
Helve, E; Karjalainen, K; Ojala, JP; Tarkkanen, A; Tikkanen, MJ	1
Bacon, SP; Cope, R; Illingworth, DR	1
Andreadis, NA; Hofmann, AF; Rossi, SS; Smith, RB; Wayne, ML; Wright, CE	1
Cuthbert, JA; East, CA; Lipsky, PE	1
Beltz, WF; Juliano, J; Kelly, N; Lester, P; Simmons, D; Steinberg, D; Weinreb, R; Witztum, JL; Young, SG	1
Schwandt, P; Weisweiler, P	1
Weisweiler, P	1
Houlston, R; Lewis, B; Quiney, J; Watts, GF	1
Bilheimer, DW; East, C; Grundy, SM	1
Stein, EA	1
Davignon, J	1
Nikkilä, EA; Tikkanen, MJ	1
Gotto, AM; Jones, PH; Scott, LW	1
Chernoff, SB; Dujovne, CA; Krehbiel, P	1
Kostis, JB; Kuo, PT; Moreyra, AE; Wilson, AC	1
Dine, M; Glueck, CJ; Laskarzewski, P; Mellies, MJ; Perry, T	1
Bilheimer, DW	1
Kane, JP; Kunitake, ST; Malloy, MJ; Tun, P	1
Jacob, B; Merk, W; Schwandt, P; Weisweiler, P	1
Kłosiewicz-Latoszek, L; Naruszewicz, M; Nowicka, G; Szostak, WB	1
Bilheimer, DW; Grundy, SM; Vega, GL	1
Levy, RI; Schaefer, EJ	1
Hüppe, R; Kohlmeier, M; Schlierf, G; Schmidt-Gayk, H; Vogel, G; Vuilleumier, JP	1
Hunninghake, DB; Lin, TL; Peters, J; Probstfield, JL	1

Reviews

10 review(s) available for colestipol and Apolipoprotein B-100, Familial Defective

Article	Year
Regression of coronary atherosclerosis in man. Advances in experimental medicine and biology, 1984, Volume: 168 Topics: Adolescent; Adult; Animals; Arteriosclerosis; Cholesterol; Colestipol; Coronary Vessels; Homozygote; Humans; Hyperlipoproteinemia Type II; Ileum; Middle Aged; Plasma Exchange; Polyamines; Time Factors	1984
Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Transactions of the Association of American Physicians, 1983, Volume: 96 Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Colestipol; Combined Modality Therapy; Dogs; Drug Therapy, Combination; Heterozygote; Humans; Hyperlipoproteinemia Type II; Ileum; Lipoproteins, LDL; Liver; Lovastatin; Naphthalenes; Receptors, LDL	1983
Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis. Annals of internal medicine, 1982, Volume: 96, Issue:4 Topics: Arteriosclerosis; Cholesterol; Colestipol; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Niacin; Nicotinic Acids; Phenols; Polyamines; Probucol	1982
Treatment of hypercholesterolemia. The Medical clinics of North America, 1982, Volume: 66, Issue:2 Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine	1982
Therapy of hyperlipidemic states. Annual review of medicine, 1982, Volume: 33 Topics: Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Colestipol; Dietary Fats; Drug Therapy, Combination; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins, LDL; Lipoproteins, VLDL; Niacin; Nicotinic Acids; Sitosterols	1982
Choosing the right lipid-regulating agent. A guide to selection. Drugs, 1996, Volume: 52, Issue:5 Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides	1996
Bile acid sequestrants. Journal of clinical pharmacology, 1990, Volume: 30, Issue:2 Topics: Chemical Phenomena; Chemistry; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lipoproteins, VLDL; Polyamines; Resins, Plant	1990
Treatment of hypercholesterolemia. Annual review of medicine, 1986, Volume: 37 Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats	1986
The diagnosis and management of hyperlipidemia. Disease-a-month : DM, 1986, Volume: 32, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides	1986
Pathogenesis and management of lipoprotein disorders. The New England journal of medicine, 1985, May-16, Volume: 312, Issue:20 Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylomicrons; Colestipol; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Hypobetalipoproteinemias; Hypolipoproteinemias; Infant; Infant, Newborn; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Tangier Disease	1985

Trials

19 trial(s) available for colestipol and Apolipoprotein B-100, Familial Defective

Article	Year
Probucol with colestipol in the treatment of hypercholesterolemia. Annals of internal medicine, 1984, Volume: 100, Issue:4 Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, HDL; Male; Middle Aged; Phenols; Polyamines; Probucol	1984
The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia. Acta paediatrica Scandinavica, 1983, Volume: 72, Issue:1 Topics: Adolescent; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Child; Cholesterol; Clinical Trials as Topic; Colestipol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Polyamines; Triglycerides	1983
Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation. Mayo Clinic proceedings, 1984, Volume: 59, Issue:4 Topics: Adenosine Diphosphate; Adult; Aged; Cholesterol; Colestipol; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Polyamines; Sitosterols; Sterols	1984
Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen. The New England journal of medicine, 1981, Jan-29, Volume: 304, Issue:5 Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Nicotinic Acids; Polyamines	1981
Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia. Archives of internal medicine, 1982, Volume: 142, Issue:4 Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Colestipol; Drug Evaluation; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; Polyamines; Triglycerides	1982
"Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia. Atherosclerosis, 1982, Volume: 41, Issue:1 Topics: Adolescent; Adult; Child; Child, Preschool; Colestipol; Dose-Response Relationship, Drug; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Polyamines	1982
Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia. Metabolism: clinical and experimental, 1981, Volume: 30, Issue:2 Topics: Adult; Aged; Cholesterol; Clofibrate; Colestipol; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Placebos; Polyamines; Random Allocation	1981
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet (London, England), 1995, Apr-01, Volume: 345, Issue:8953 Topics: Adult; Blood Component Removal; Cholestyramine Resin; Colestipol; Coronary Angiography; Coronary Artery Disease; Data Interpretation, Statistical; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lovastatin; Middle Aged; Odds Ratio; Simvastatin	1995
Low dose colestipol in adolescents with familial hypercholesterolaemia. Archives of disease in childhood, 1996, Volume: 74, Issue:2 Topics: Adolescent; Body Height; Body Weight; Child; Colestipol; Diet; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Male; Micronutrients; Patient Compliance	1996
Colestipol tablets in adolescents with familial hypercholesterolaemia. Acta paediatrica (Oslo, Norway : 1992), 1996, Volume: 85, Issue:9 Topics: Adolescent; Child; Colestipol; Drug Administration Schedule; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Male; Patient Compliance; Tablets	1996
Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study Group. Atherosclerosis, 1998, Volume: 136, Issue:1 Topics: Adult; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Genotype; Heterozygote; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Phenotype; Receptors, LDL; Simvastatin	1998
The familial hypercholesterolemia regression study: a randomized comparison of therapeutic reduction of both low-density lipoprotein and lipoprotein(a) versus low-density lipoprotein alone. Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis, 1997, Volume: 1, Issue:2 Topics: Colestipol; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins, LDL; Prospective Studies; Simvastatin; Treatment Outcome	1997
Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:5 Topics: Anticholesteremic Agents; Atorvastatin; Cholestenones; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemia Type II; Male; Mevalonic Acid; Middle Aged; Mutation; Pyrroles; Receptors, LDL; RNA, Messenger	2001
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Radiographic Image Interpretation, Computer-Assisted; Triglycerides	1990
Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride. Circulation, 1989, Volume: 79, Issue:1 Topics: Cholesterol; Clinical Trials as Topic; Colestipol; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Phenols; Polyamines; Probucol; Prospective Studies; Triglycerides; Xanthomatosis	1989
Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia. Metabolism: clinical and experimental, 1989, Volume: 38, Issue:3 Topics: Adolescent; Adult; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Polyamines; Propionates; Random Allocation	1989
Combination drug therapy for familial combined hyperlipidemia. Annals of internal medicine, 1988, Jul-01, Volume: 109, Issue:1 Topics: Adult; Cholelithiasis; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pentanoic Acids; Polyamines; Random Allocation; Ultrasonography; Valerates	1988
Controlled studies of the efficacy and safety of combined probucol-colestipol therapy. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Phenols; Polyamines; Probucol; Prospective Studies; Time Factors	1986
Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Combined Modality Therapy; Coronary Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Phenols; Polyamines; Probucol; Triglycerides	1986

Other Studies

47 other study(ies) available for colestipol and Apolipoprotein B-100, Familial Defective

Article	Year
Treatment of children with familial hypercholesterolemia with colestilan, a newly developed bile acid-binding resin. Atherosclerosis, 2002, Volume: 164, Issue:2 Topics: Administration, Oral; Adolescent; Anion Exchange Resins; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Male; Probability; Prospective Studies; Sampling Studies; Severity of Illness Index; Treatment Outcome; Triglycerides	2002
Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans. Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:2 Topics: Adult; Atorvastatin; Bile Acids and Salts; Child; Cholesterol, LDL; Colestipol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heptanoic Acids; Heterozygote; Human Growth Hormone; Humans; Hyperlipoproteinemia Type II; Hypopituitarism; Lipoproteins, LDL; Male; Middle Aged; Pyrroles	2004
Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholeserolemia heterozygotes. 1983. Atherosclerosis. Supplements, 2004, Volume: 5, Issue:3 Topics: Colestipol; History, 20th Century; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lovastatin	2004
Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia. Lancet (London, England), 1981, Feb-07, Volume: 1, Issue:8215 Topics: Adult; Colestipol; Drug Therapy, Combination; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Nicotinic Acids; Polyamines	1981
Drugs for familial hypercholesterolaemia. Lancet (London, England), 1981, Apr-25, Volume: 1, Issue:8226 Topics: Colestipol; Drug Synergism; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Nicotinic Acids	1981
Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia. Annals of internal medicine, 1984, Volume: 101, Issue:5 Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Polyamines	1984
Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proceedings of the National Academy of Sciences of the United States of America, 1983, Volume: 80, Issue:13 Topics: Anticholesteremic Agents; Colestipol; Genetic Carrier Screening; Humans; Hyperlipoproteinemia Type II; Kinetics; Lipoproteins, LDL; Lovastatin; Naphthalenes; Polyamines	1983
Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia. Proceedings of the National Academy of Sciences of the United States of America, 1983, Volume: 80, Issue:24 Topics: Cholesterol; Colestipol; Heterozygote; Homeostasis; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neutrophils; Nicotinic Acids; Phosphatidylcholines; Polyamines; Reference Values	1983
Therapy of familial and acquired hyperlipoproteinemia in children and adolescents. Preventive medicine, 1983, Volume: 12, Issue:6 Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Infant; Infant Food; Lipoproteins, LDL; Male; Patient Compliance; Triglycerides	1983
Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood. Preventive medicine, 1983, Volume: 12, Issue:6 Topics: Adolescent; Child; Child, Preschool; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Plasma Exchange; Polyamines	1983
Treating hyperlipidemia to provide salutary effect on coronary artery disease. Chest, 1984, Volume: 85, Issue:4 Topics: Arteriosclerosis; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Lipoproteins, LDL	1984
Treatment of the arthropathy of familial hypercholesterolaemia. Annals of the rheumatic diseases, 1983, Volume: 42, Issue:2 Topics: Adult; Arthritis; Cholesterol; Colestipol; Female; Humans; Hyperlipoproteinemia Type II	1983
Protection of myocardium by the compensatory mechanism of coronary collaterals after total occlusion of major coronary arteries shown in patients with familial hypercholesterolemia. American heart journal, 1982, Volume: 104, Issue:1 Topics: Adult; Arterial Occlusive Diseases; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Colestipol; Coronary Circulation; Coronary Disease; Electrocardiography; Female; Heart; Heart Function Tests; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Niacin; Nicotinic Acids; Radiography; Radionuclide Imaging	1982
Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia. Metabolism: clinical and experimental, 1981, Volume: 30, Issue:6 Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Colestipol; Dose-Response Relationship, Drug; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Polyamines; Triglycerides	1981
Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia. Metabolism: clinical and experimental, 1981, Volume: 30, Issue:6 Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Colestipol; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Polyamines; Triglycerides	1981
[Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol]. Srpski arhiv za celokupno lekarstvo, 1980, Volume: 108, Issue:9 Topics: Adult; Cholesterol; Colestipol; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Polyamines	1980
[The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1981, Volume: 18, Issue:6 Topics: Adult; Aged; Colestipol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Middle Aged; Polyamines	1981
Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol. Pediatrics, 1980, Volume: 65, Issue:2 Topics: Adolescent; Calcium; Child; Child, Preschool; Cholesterol, Dietary; Colestipol; Female; Folic Acid; Humans; Hydroxycholecalciferols; Hyperlipoproteinemia Type II; Intestinal Absorption; Lipoproteins, LDL; Male; Polyamines; Vitamin A; Vitamins	1980
[Familial hypercholesterolemic xanthomatosis: effect of colestipol on the lipoprotein profile]. La Nouvelle presse medicale, 1980, Nov-08, Volume: 9, Issue:42 Topics: Colestipol; Hyperlipoproteinemia Type II; Polyamines; Xanthomatosis	1980
Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment. Chest, 1981, Volume: 79, Issue:3 Topics: Adult; Angiography; Cholesterol; Cholesterol, Dietary; Colestipol; Coronary Angiography; Coronary Disease; Coronary Vessels; Dietary Carbohydrates; Dietary Fats; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Nicotinic Acids; Polyamines; Triglycerides	1981
Low-density-lipoprotein apheresis. Lancet (London, England), 1995, Jul-08, Volume: 346, Issue:8967 Topics: Anticholesteremic Agents; Blood Component Removal; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lovastatin; Simvastatin	1995
Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100. Atherosclerosis, 1993, Jan-25, Volume: 98, Issue:2 Topics: Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Triglycerides	1993
Treatment of the patient with primary familial heterozygous hypercholesterolemia. The Journal of cardiovascular nursing, 1995, Volume: 9, Issue:2 Topics: Aged; Colestipol; Coronary Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Exercise; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Patient Compliance; Weight Loss	1995
Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride. The Journal of clinical endocrinology and metabolism, 1978, Volume: 46, Issue:5 Topics: Colestipol; Humans; Hyperlipoproteinemia Type II; Polyamines; Thyroid Function Tests; Thyroid Hormones; Thyrotropin	1978
Growth during treatment of familial hypercholesterolemia. Acta paediatrica (Oslo, Norway : 1992), 1992, Volume: 81, Issue:12 Topics: Child; Child, Preschool; Colestipol; Dietary Fats; Female; Growth; Humans; Hyperlipoproteinemia Type II; Infant; Male; Retrospective Studies	1992
[Colestipol in the treatment of heterozygous familial hypercholesterolemia]. Casopis lekaru ceskych, 1992, Mar-04, Volume: 131, Issue:4 Topics: Adolescent; Adult; Aged; Child; Colestipol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged	1992
[Combined therapy of hyperlipoproteinemia. Colestipol and gemfibrozil in the treatment of heterozygous familial hypercholesterolemia]. Casopis lekaru ceskych, 1992, Mar-27, Volume: 131, Issue:6 Topics: Adult; Aged; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged	1992
Lecithin: cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol. Journal of clinical pharmacology, 1991, Volume: 31, Issue:6 Topics: Adolescent; Adult; Anticholesteremic Agents; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Simvastatin	1991
[Small doses of the resin Colestid in the treatment of hyperlipoproteinemia]. Casopis lekaru ceskych, 1991, Feb-08, Volume: 130, Issue:6 Topics: Colestipol; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged	1991
The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia. The Netherlands journal of medicine, 1990, Volume: 36, Issue:3-4 Topics: Adult; Apolipoproteins; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides	1990
Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up. Atherosclerosis, 1990, Volume: 82, Issue:1-2 Topics: Adult; Aged; Cholesterol, LDL; Colestipol; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Polyamines; Probucol; Triglycerides	1990
Regression of tendon xanthomas in patients with familial hypercholesterolemia treated with lovastatin. Southern medical journal, 1990, Volume: 83, Issue:9 Topics: Achilles Tendon; Adult; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Radiography; Remission Induction; Tendons; Wolman Disease	1990
Effect of the bile-acid sequestrant colestipol on postprandial serum bile-acid concentration: evaluation by bioluminescent enzymic analysis. Alimentary pharmacology & therapeutics, 1989, Volume: 3, Issue:1 Topics: Adolescent; Adult; Bile Acids and Salts; Cholesterol; Colestipol; Eating; Enzymes; Humans; Hyperlipoproteinemia Type II; Luminescent Measurements; Male; Middle Aged; Triglycerides	1989
Normalization of LDL receptor function by lymphocytes of patients with heterozygous familial hypercholesterolemia after treatment with plasma cholesterol lowering agents. The American journal of the medical sciences, 1989, Volume: 298, Issue:3 Topics: Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Drug Combinations; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, LDL; Lovastatin; Lymphocytes; Receptors, Cell Surface; Receptors, Lipoprotein; Reference Values	1989
Colestipol plus fenofibrate versus synvinolin in familial hypercholesterolaemia. Lancet (London, England), 1986, Nov-22, Volume: 2, Issue:8517 Topics: Adult; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Polyamines; Propionates	1986
Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia. Journal of the Royal Society of Medicine, 1988, Volume: 81, Issue:5 Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Male; Pentanoic Acids; Triglycerides; Valerates	1988
Drug therapy in children and adolescents with familial hypercholesterolemia. Progress in clinical and biological research, 1988, Volume: 255 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Infant; Male; Niacin	1988
Medical management of hyperlipidemia and the role of probucol. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk	1986
Current pharmacologic treatment of elevated serum cholesterol. Circulation, 1987, Volume: 76, Issue:3 Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides	1987
Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia. Pediatrics, 1986, Volume: 78, Issue:2 Topics: Adolescent; Behavior; Bile Acids and Salts; Body Height; Body Weight; Child; Cholesterol; Cholestyramine Resin; Colestipol; Drug Evaluation; Evaluation Studies as Topic; Female; Follow-Up Studies; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Polyamines; Sexual Maturation	1986
Lipoprotein fractions and receptors: a role for probucol? The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Anticholesteremic Agents; Biological Transport; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, HDL; Lipoproteins, IDL; Lipoproteins, VLDL; Lovastatin; Naphthalenes; Phenols; Probucol; Receptors, LDL	1986
Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia. Annals of internal medicine, 1987, Volume: 107, Issue:5 Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Polyamines	1987
Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia. European journal of clinical pharmacology, 1986, Volume: 30, Issue:2 Topics: Adult; Apolipoproteins; Body Weight; Cholesterol; Cholesterol, HDL; Colestipol; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Polyamines; Propionates	1986
Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia. Atherosclerosis, 1987, Volume: 63, Issue:2-3 Topics: Adult; Aged; Apolipoproteins B; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Polyamines	1987
Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia. Annals of internal medicine, 1985, Volume: 103, Issue:3 Topics: Adult; Apolipoproteins; Bile Acids and Salts; Cholesterol; Colestipol; Combined Modality Therapy; Drug Therapy, Combination; Enterohepatic Circulation; Female; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Ileum; Kinetics; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Naphthalenes	1985
[Long-term therapy of familial hypercholesterolemia in young patients with colestipol: availability of minerals and vitamins]. Klinische Wochenschrift, 1985, Sep-02, Volume: 63, Issue:17 Topics: Adolescent; Adult; Blood Glucose; Calcium; Child; Child, Preschool; Chlorides; Colestipol; Coronary Disease; Female; Humans; Hyperlipoproteinemia Type II; Iron; Lipids; Long-Term Care; Male; Minerals; Parathyroid Hormone; Phosphates; Polyamines; Potassium; Sodium; Vitamins	1985
Carotenoids and vitamin A: the effect of hypocholesterolemic agents on serum levels. Metabolism: clinical and experimental, 1985, Volume: 34, Issue:1 Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Carotenoids; Cellulose; Cholesterol, LDL; Clofibrate; Colestipol; Humans; Hyperlipoproteinemia Type II; Middle Aged; Vitamin A	1985